Regulation
Nutromics’ drug monitoring patch secures FDA breakthrough designation
Nutromics has received FDA Breakthrough Device designation for its wearable drug-monitoring patch, which tracks vancomycin levels. The designation accelerates review pathways for the platform and signals FDA recognition of the technology's potential clinical value in therapeutic drug monitoring.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network